The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT02973529

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02973529
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark, Latvia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02973529. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
Acronym
BIFSORB
Intervention (Device)
Absorb
Intervention (Device)
Desolve
Lead sponsor
Aarhus University Hospital Skejby (class: other)

Record details

Record id
cardio:ct-nct02973529
Content hash
417fedba6fec182f137962113e430f152b6b84a1f7f9685b2ae803a801063464